FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1235.329

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113762.1.4.1235.329
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1235.329/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.329
Version20230616
Statusactive
Date2023-06-16T01:00:56-04:00
NameHighRiskHPVTest_HD_HCPCS
TitleHigh Risk HPV Test_HD_HCPCS
Realmus
Authorityhl7
Descriptionb.well created value set by Sr. Clinical Business Analyst for High Risk HPV Test.
Purpose(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute High Risk HPV Test for inclusion and utilization in patients/users connected heath.),(Data Element Scope: High Risk HPV Test for b.well.),(Inclusion Criteria: High Risk HPV Test Codes that constitute a Cancer Care Need for b.well.),(Exclusion Criteria: N/A)

Resources that use this resource

ValueSet
2.16.840.1.113762.1.4.1235.332High Risk HPV Test_HD_Grouping

Resources that this resource uses

CodeSystem
HCPCSReleaseCodeSetsHealthcare Common Procedure Coding System (HCPCS) level II alphanumeric codes

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1235.329",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "B.well Connected Health Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-07-02"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2023-06-16"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.329",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1235.329"
    }
  ],
  "version": "20230616",
  "name": "HighRiskHPVTest_HD_HCPCS",
  "title": "High Risk HPV Test_HD_HCPCS",
  "status": "active",
  "date": "2023-06-16T01:00:56-04:00",
  "publisher": "B.well Connected Health Steward",
  "description": "b.well created value set by Sr. Clinical Business Analyst for High Risk HPV Test.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute High Risk HPV Test for inclusion and utilization in patients/users connected heath.),(Data Element Scope: High Risk HPV Test for b.well.),(Inclusion Criteria: High Risk HPV Test Codes that constitute a Cancer Care Need for b.well.),(Exclusion Criteria: N/A)",
  "compose": {
    "include": [
      {
        "system": "http://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets",
        "concept": [
          {
            "code": "G0476",
            "display": "Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:3835fb96-1cce-4e49-aedb-40a5c95d7a7f",
    "timestamp": "2025-05-23T20:23:10-04:00",
    "total": 1,
    "contains": [
      {
        "system": "http://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets",
        "version": "2025",
        "code": "G0476",
        "display": "Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test"
      }
    ]
  }
}